BAC
Bank of America Corporation
BAC has the edge over PNNT overall, supported by stronger valuation and stronger fundamentals.
PNNT
PennantPark Investment Corporation
PNNT trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
PNNT Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Healthy | |
| N/A | |
| N/A |
PNNT's profitability is currently healthy, but its revenue is weak. Free cash flow and net leverage aren't meaningful measures for financial services companies like PNNT.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over PNNT in the historical PE scenario, which offers more potential upside but is not a forecast.
PNNT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 3x | $0.49 | -85% |
| Forward | 5.6x | $3.25 | — |
| Fair | 7.5x | $1.19 | -63% |
| Expensive | 20x | $3.23 | -0.5% |
| Current | 21x | $3.25 | — |
Historical ranges are pointers, not guarantees.
PNNT's PE is in its expensive range at 21x. On analysts' estimates for next year's earnings, today's price would be 5.6x, in its fair range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over PNNT on the outlook, with more favorable earnings and revenue expectations.
PNNT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Stable | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect PNNT's profitability to improve, with its earnings and revenue holding steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the stronger earnings trend. Trailing diluted EPS is up 14% for BAC versus PNNT down 91%.
PNNT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.58 | +260% |
| Q2 2023 | -$1.23 | -337% |
| Q1 2023 | -$1.83 | -243% |
| Q4 2022 | -$1.85 | -203% |
| Q3 2022 | -$0.37 | -115% |
| Q2 2022 | $0.52 | -77% |
| Q1 2022 | $1.28 | -36% |
| Q4 2021 | $1.80 | +240% |
| Q3 2021 | $2.48 | +$2.72 |
PNNT has returned to profit: it earned $0.16 per share over the past year, after losing money the year before.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the stronger quarterly revenue trend. Revenue is up 6.7% for BAC versus down 185% for PNNT.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
PNNT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2022 | $12M | -73% |
| Q4 2021 | $40.3M | -48% |
| Q3 2021 | $31.8M | +66% |
| Q2 2021 | $39.9M | +70% |
| Q4 2020 | $77.4M | +162% |
| Q3 2020 | $19.2M | -13% |
PNNT's revenue has slid since its 2020 peak: −$27M last quarter, down 185% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2022 | 28% | -58 points |
| Q4 2021 | 76% | -16 points |
| Q3 2021 | 79% | +28 points |
| Q2 2021 | 80% | +13 points |
| Q1 2021 | 86% | N/A |
| Q4 2020 | 92% | +26 points |
| Q3 2020 | 51% | +12 points |
| Q2 2020 | 68% | N/A |
PNNT's operating margin was 28% last quarter, down 58 points from the same quarter a year ago, near the bottom of its range since 2019.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
PNNT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $50.1M | -2.7% |
| Q1 2026 | $36.4M | -74% |
| Q4 2025 | $134.5M | +618% |
| Q3 2025 | -$107.8M | -$103.1M |
| Q2 2025 | $51.5M | +$68.3M |
| Q1 2025 | $142.4M | +3247% |
| Q4 2024 | $18.7M | +$173.9M |
| Q3 2024 | -$4.7M | -104% |
PNNT's free cash flow was $113M over the past year, down 46% from the year before. Free cash flow isn't a meaningful measure for financial services companies like PNNT.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over PNNT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
PNNT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | 0% | -- |
| 3 years | +0.1% | +71.6K shares |
| 5 years | -2.6% | -1.7M shares |
| Available history | -2.6% | -1.7M shares |
PNNT has 65M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2022 | $1.2M |
| Q2 2022 | $5M |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
PNNT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2022 | 14.2x | High |
| Q1 2022 | 5.7x | High |
| Q4 2021 | 6.1x | High |
| Q3 2021 | 3.5x | Elevated |
| Q2 2021 | 3.2x | Elevated |
| Q1 2021 | 1.6x | Healthy |
| Q4 2020 | 2.4x | Moderate |
| Q3 2020 | 3.2x | Elevated |
PNNT's net debt is about 14 years of its operating earnings (EBITDA), up from 3.2 years a year ago. Net leverage isn't a meaningful measure for financial services companies like PNNT.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
PNNT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.3 | Neutral |
| Stochastic | 37.8 | Neutral |
PNNT's weekly RSI is 39 (neutral) and its Stochastic is 38 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over PNNT on valuation relative to its sector.
PNNT PE vs Financial Services Sector
| Metric | PNNT | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 13x | 61% above |
| PE % | 84 | 63 | 21 pts above |
PNNT is trading at 21x earnings, a 61% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
PNNT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.16 | 2.8% above |
| 20 week MA | $3.38 | 3.8% below |
| 50 week MA | $4.28 | 24% below |
| 100 week MA | $5.56 | 42% below |
| 200 week MA | $6.05 | 46% below |
PNNT has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 46% below its 200-week average.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has the edge over PNNT on returns for 2026, with the stronger performance.
PNNT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6.60 | $4.52 | -32% |
| 2021 | $4.52 | $6.88 | +52% |
| 2022 | $6.88 | $5.65 | -18% |
| 2023 | $5.65 | $6.91 | +22% |
| 2024 | $6.91 | $6.99 | +1.2% |
| 2025 | $6.99 | $5.93 | -15% |
| 2026 YTD | $5.93 | $3.25 | -45% |
PNNT has finished lower in three of the last six years. It's down 45% so far in 2026.